Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Capital Expenditures (2016 - 2026)

Cryo Cell International's Capital Expenditures history spans 17 years, with the latest figure at $67065.0 for Q1 2026.

  • Quarterly results put Capital Expenditures at $67065.0 for Q1 2026, up 8.08% from a year ago — trailing twelve months through Feb 2026 was $235487.0 (down 88.27% YoY), and the annual figure for FY2025 was $230475.0, down 90.41%.
  • Capital Expenditures for Q1 2026 was $67065.0 at Cryo Cell International, roughly flat from $67226.0 in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $11.2 million in Q3 2022 to a low of -$25011.0 in Q4 2022.
  • The 5-year median for Capital Expenditures is $306970.0 (2022), against an average of $1.3 million.
  • The sharpest move saw Capital Expenditures plummeted 108.93% in 2022, then soared 6956.64% in 2023.
  • Year by year, Capital Expenditures stood at -$25011.0 in 2022, then soared by 6956.64% to $1.7 million in 2023, then tumbled by 99.51% to $8348.0 in 2024, then skyrocketed by 705.29% to $67226.0 in 2025, then fell by 0.24% to $67065.0 in 2026.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $67065.0, $67226.0, and $38788.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.